Trial · NCT02912988
Registered outcomes20
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 20
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Live birth rate | through study completion, an average of 1 year | A baby born alive after 20 weeks gestation |
| Secondary | Miscarriage rate | up to 20 weeks of gestation | Miscarriage before 20 weeks gestation |
| Secondary | Clinical and ongoing pregnancy rates | up to 20 weeks | Presence of at least one gestational sac on ultrasound at 6 weeks and 8-10 weeks |
| Secondary | Ovarian hyperstimulation rate | about 1 month | Ovarian hyperstimulation rate classified according to Royal College of Obstetrics and Gynaecology of the United Kingdom |
| Secondary | Total IU of FSH used per cycle | about 2 weeks | Total IU of FSH used per cycle |
| Secondary | Number of follicles > 12 mm on day of hCG (or the day before) | about 2 weeks | Transvaginal ultrasound performed to measure and the follicles on day of hcG or the day before. |
| Secondary | Number of oocytes obtained | On the operation day of transvaginal ultrasound guided oocyte retrieval | Number of oocyte obtained during the operation of transvaginal ultrasound guided oocyte retrieval |
| Secondary | Proportion of oocytes resulting in top quality day 2 (or day 3) embryos according to validated morphological criteria. | 2-3 days after the transvaginal ultrasound guided oocyte retrieval operation | Proportion of oocytes resulting in top quality day 2 (or day 3) embryos according to validated morphological criteria. |
| Secondary | Oocyte fertilization rate | 2-3 days after the transvaginal ultrasound guided oocyte retrieval operation | Oocyte fertilization rate |
| Secondary | Number and quality of embryos obtained | 2-3 days after the transvaginal ultrasound guided oocyte retrieval operation | Number and quality of embryos obtained |
| Secondary | Endometrial thickness on day of hCG (or the day before) | on day of hCG (or the day before) | Endometrial thickness on day of hCG (or the day before) measured by transvaginal ultrasound |
| Secondary | Serum E2 level on day of hCG administration (or the day before) | on day of hCG administration (or the day before) | Hormonal profile on day of hCG administration (or the day before): serum E2 level |
| Secondary | Serum P levels on day of hCG administration (or the day before) | on day of hCG administration (or the day before) | Hormonal profile on day of hCG administration (or the day before): sSerum P level |
| Secondary | Serum testosterone levels on day of hCG administration (or the day before) | on day of hCG administration (or the day before) | Hormonal profile on day of hCG administration (or the day before):serum testosterone level |
| Secondary | Follicular fluid E2 level | On the operation day of transvaginal ultrasound guided oocyte retrieval | Follicular fluid hormonal profile: E2 level |
| Secondary | Follicular fluid testosterone level | On the operation day of transvaginal ultrasound guided oocyte retrieval | Follicular fluid hormonal profile: testosterone level |
| Secondary | Follicular fluid inhibin B level | On the operation day of transvaginal ultrasound guided oocyte retrieval | Follicular fluid hormonal profile: inhibin B level |
| Secondary | Follicular fluid AMH level | On the operation day of transvaginal ultrasound guided oocyte retrieval | Follicular fluid AMH level |
| Secondary | Reported side effects | through study completion, an average of 1 year | |
| Secondary | Complications of pregnancy | through study completion, an average of 1 year | small for gestational age, low birth weight, preterm delivery, pre-eclampsia, antepartum haemorrhage, congenital anomaly, perinatal mortality, multiple pregnancy |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02912988/registered